ERIN COOPER: Open Payments
NPI 1427483155 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,291 in 55 payments from 18 companies in 2025. Trend: 2023 $1,183 · 2024 $1,184 · 2025 $1,291
Food & beverage: $1,291
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $332 |
| Novo Nordisk Inc | 7 | $214 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $120 |
| Merck Sharp & Dohme LLC | 5 | $110 |
| Boston Scientific Corporation | 3 | $106 |
| Actelion Pharmaceuticals US, Inc. | 2 | $64 |
| PFIZER INC. | 3 | $53 |
| E.R. Squibb & Sons, L.L.C. | 3 | $53 |
| Amgen Inc. | 3 | $51 |
| Ionis Pharmaceuticals, Inc. | 1 | $31 |
Products named: LEQVIO, Wegovy, JARDIANCE, VERQUVO, General - Therapies, OPSYNVI, VYNDAQEL, REPATHA.
Industry payments across GA — which companies pay providers there.
